Soha Bazyar, MD, PhD
@sohabazyar
Mom, Wife, Bioengineer š©š»āāļø PGY-5 RadOnc @UMarylandRadOnc
ID: 1191780739110424576
05-11-2019 18:14:16
174 Tweet
282 Followers
412 Following
Our heart is broken. Tragic day University of Maryland Radiation Oncology , Itās unimaginable to see one of our own in such a critical condition. Please consider donating and keep him and his family in your prayers. gofundme.com/f/support-for-ā¦
Please join me on Monday 9/30 at 10:45 am Room#150 to learn about the role of liquid biopsy in oligometastatic castration sensitive prostate cancer. University of Maryland Radiation Oncology
For select breast cancer patients with complete response to neoadjuvant systemic therapy, radiotherapy alone without breast surgery may be feasible, as no tumor recurrences were observed at 5-year follow-up. ja.ma/426mLaK Henry Kuerer HelenMJohnsonMD Simona F. Shaitelman MD, EdM
After sharing that another patient was denied life-saving care, so many of you asked: What can I do? This is it. Thereās a resolution before the House of Representatives that would allow physicians to own hospitals againāsomething we havenāt been able to do since the Affordable
Congrats to this yearās #radonc medical resident grads! Colleagues celebrated during graduation dinner, where certificates & diplomas were awarded & outstanding accomplishments celebrated. Left to right: Drs. Hua-Ren Ryan Cherng Ryan Cherng, Soha Bazyar Soha Bazyar, MD, PhD & James Assif.
Iāve been keeping something from you. The way I cope with hard things is by doing the work and putting the pain in a box. But the truth isāsince I spoke out against insurance companies, things have been really hard. My practice is struggling. I built a surgery center so I could
Letās be real. I spoke out against a big insurance company and now Iām being punished for it. But Iām not giving up. Itās not in my blood. I heard you asking, and if you would like to help, Iāve started a gofundme (linked below) where you can read the details and consider
š Could Radiation āHeat Upā Cold Tumors? New Evidence in NSCLC! OncoAlert šÆ Objective Evaluate whether ā¢ļø enhances immunotherapy efficacy in TMB-low, PDL1-null, or Wnt-mutated NSCLC š„ Methods ⢠Design: Phase 2 RCT (NCT02492568) ⢠Arms: Pembrolizumab ± SBRT (3x8Gy before
It is an honor to be featured in the news this October, in recognition of Breast Cancer Awareness Month, to discuss the critical role of radiation therapy in breast cancer care. LifeBridge Health cbsnews.com/baltimore/newsā¦